Combat Immune Senescence

If we are to live longer, healthier lives, we need our immune system to function at peak capacity.

The following plant-derived compounds have shown an ability to help rescue the immune system from senescent decline:

• Cistanche
• Reishi mushrooms
• Pu-erh tea

Together, these natural extracts help combat immune senescence by several complementary mechanisms that include enhancing activity of natural killer cells and T cells and turning down overactive immune reactions.

This article describes research supporting the use of low-cost plant extracts to help support immune health.

Reishi Mushrooms Extract

The immune-boosting properties of Reishi mushrooms have been appreciated in Eastern medicine for thousands of years. Modern science is now validating their health-promoting properties.^1,2

Studies show that consuming these mushrooms improves immune function and has anti-tumor effects.^2-9

In mice, Reishi has been found to promote the maturation and activation of immune system cells such as T cells, natural killer cells, dendritic cells, and macrophages.^3-6

Lab studies show that Reishi also helps raise protective IL-10 levels and lower pro-inflammatory IL-6 levels.^10,11

This indicates that Reishi augments the function of both the innate and adaptive immune system.

The innate immune system can be thought of as the body’s first line of defense, responding rapidly to potentially harmful insults such as viruses, bacteria, and cancer cells.

Natural killer cells are an important component of this innate immunity.^12-17 The diminished activity of natural killer cells that occurs with aging predisposes the elderly to high rates of infection by viruses ranging from influenza to various herpes viruses.^16-21

The adaptive immune system responds more slowly than the innate immune system but mounts a more specific, powerful attack against pathogens using specialized immune system cells called T cells.

With its ability to boost components of both innate and adaptive immunity, Reishi can protect the aging body from infections. This benefit has been borne out in laboratory studies demonstrating activity against many common viruses, including:

• Herpes simplex viruses—which cause oral and genital herpes²²
• Influenza viruses—which cause the flu²³
• Epstein-Barr virus—which causes mono- nucleosis but can also contribute to the formation of cancer^24,25
• Hepatitis B virus—a common cause of liver disease that can lead to liver failure^26,27
• Human immunodeficiency virus (HIV)— the virus which causes AIDS^28,29

Anti-Cancer Properties

In addition to supporting protection from infection, Reishi exhibits anti-cancer properties as well—largely because of its ability to enhance immune function.

In particular, the boost Reishi gives to natural killer cell, T cell, and macrophage function aids in the identification and destruction of abnormal cells that may develop into cancer.^2,9

Reishi may also directly combat tumors through an array of mechanisms it has demonstrated in the lab: impairing the ability of tumor cells to grow, preventing tumor blood vessels from developing, starving the abnormal cells, and even directly killing cancer cells.^2,9

In one study, Reishi mushrooms were applied to various human cancer cell lines.⁹ Not only did the Reishi reduce the growth of the cells, but it induced cell death in many of the diseased cells.

Lifespan Extension

Perhaps most impressively, Reishi has been shown to significantly extend lifespan of mice.³⁰ Researchers followed two groups of mice, one fed a normal control diet and the other fed a diet enriched with a Reishi extract.

The Reishi supplemented group lived as much as 148 days longer than the control group. Given that the lifespan of a mouse is typically less than two years, this represents a dramatic increase in longevity.

Cistanche Extract

Cistanche is a type of desert plant that, like Reishi mushrooms, has long been appreciated for its medicinal uses in Eastern medicine.

Several studies have confirmed the ability of Cistanche extract to boost immune cells in the body.^41-44

In one study, researchers utilized a strain of senescence-accelerated mice. These mice age more rapidly than normal mice and display the same deterioration in immune function seen in human immune senescence.

The mice fed a diet supplemented with Cistanche extract for four weeks had a significantly increased number of T cells and natural killer cells in the blood, and lower pro-inflammatory interleukin-6 (IL-6) levels.

This enhancement in immune function translated to an extended lifespan as well. The average age after supplementation with Cistanche was 15% longer than the controls’.⁴¹

In addition to T cells and natural killer cells, Cistanche also helps activate other important immune cells, including macrophages, dendritic cells, and B cells.^42,43

Encouraging results have been demonstrated in a human study as well. When elderly subjects took 100 mg of Cistanche extract daily for 12 weeks, there was a 6.1% increase in helper T cells and an almost 12% increase in natural killer cell activity. This increase represents an immune-boosting effect.⁴⁴

Patients also experienced improved markers of vascular function and a decrease in fatigue. No significant adverse effects were observed.

Given that these same improvements in immune function resulted in enhanced longevity in animal studies, it can be hoped that the rejuvenating effect Cistanche has on the human immune system may assist in prolonging lifespan in people as well.

A hallmark marker of longevity potential is blood levels of interleukin-6 (IL-6).

Older individuals with higher levels of IL-6 tend to not live as long and tend to have a higher burden of chronic disease. On the other hand, older people with lower IL-6 levels tend to be healthier and have better prospects for even longer lives.

This makes sense because elevated IL-6 generates chronic inflammatory signals that result in tissue damage throughout the body.^45-49

Pu-erh Tea Extract’s Immune Effects

A fermented black tea called Pu-erh has shown benefits for the aging immune system.⁵⁰

Studies show that Pu-erh tea and its extract combat immune senescence by multiple mechanisms.⁵⁰ Two of the chief ones include increasing natural killer and T cells.

In addition to its ability to bolster the immune system itself, Pu-erh tea appears to provide direct antibacterial and antiviral effects as well. Several studies have demonstrated that Pu-erh tea directly kills or inhibits the growth of bacteria and suppresses the growth of viruses such as hepatitis B.⁵⁰

In one investigation, scientists studied the effects of Pu-erh tea on the senescence-accelerated strain of mice discussed previously.⁵¹

Before supplementation with Pu-erh tea, the mice demonstrated the same features of immune system deterioration seen in aging humans, including lower numbers of active T cells and natural killer cells.

In addition, levels of the powerful pro-inflammatory cytokine IL-6 were markedly elevated in the senescence-accelerated mice, compared with controls.

Feeding these mice with Pu-erh tea reversed these markers of immune senescence.

The treated mice experienced enhanced numbers of T cells and natural killer cells and a significant 43% decrease in IL-6—benefits that more closely resemble a normal, healthy immune system.

Based on these immune-boosting results, the researchers concluded that intake of Pu-erh tea may help older individuals prevent infection and cancer.

Anti-Inflammatory Effects in Humans

A human study of Pu-erh tea extract further demonstrated its role in reversing inflammatory cytokine levels.

The study was performed among a group of patients with metabolic syndrome, a common condition defined by central obesity, borderline or high fasting glucose, high blood pressure, and elevated blood lipids.⁵² Those with metabolic syndrome have higher levels of inflammation and are at an increased risk of having immune impairments.⁵³

Subjects were given either Pu-erh tea extract twice daily or a placebo. They were instructed to exercise and observe a healthy diet during the study period but were permitted no medicines that might otherwise affect the results.

After three months, patients provided blood samples for analysis of inflammatory cytokines and other markers of inflammation.

As expected, placebo recipients showed no significant changes in blood levels of TNF-a or IL-6 (pro-inflammatory cytokines), IL-10 (an anti-inflammatory cytokine), or C-reactive protein (CRP, a marker of total body inflammation).

Subjects supplemented with Pu-erh tea extract showed improvements in immune status as follows:

• 21% reduction in IL-6,
• 23% reduction in TNF-a, and
• 26% reduction in CRP.

These reductions indicate significant decreases in overall pro-inflammatory status.

This study also found a 34% increase of inflammation-quelling IL-10, which further demonstrates the overall reduction in inflammation possible with Pu-erh tea extract.

Pu-erh tea extract offers multiple pathways to potentially prevent progress of immune senescence.

Summary

Immune senescence occurs as people age and puts the elderly at increased risk for infections, cancers, and a variety of chronic inflammatory diseases.

Compounds naturally found in certain plants and fungi bolster weakened immune systems.

Reishi mushrooms, Cistanche, and Pu-erh tea can improve immune function by several complementary mechanisms, including amplifying the activity of natural killer cells, T cells, and various other immune system components.

They also help suppress over-activity of immune cells that can result in damaging inflammatory reactions.

Adding these nutrients to a healthy diet can help induce improvements in immune cell markers in older age.

If you have any questions on the scientific content of this article, please call a Life Extension® Wellness Specialist at 1-866-864-3027.

References

1. Babu PD, Subhasree R. The sacred mushroom “Reishi”-a review. American-Eurasian Journal of Botany. 2008;1(3):107-10.
2. Xu Z, Chen X, Zhong Z, et al. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39(1):15-27.
3. Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett. 2002 Oct 1;83(3):163-9.
4. Chang CJ, Chen YY, Lu CC, et al. Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin. Innate Immun. 2014 Apr;20(3):301-11.
5. Wang PY, Zhu XL, Lin ZB. Antitumor and Immunomodulatory Effects of Polysaccharides from Broken-Spore of Ganoderma lucidum. Front Pharmacol. 2012;3:135.
6. Chang YH, Yang JS, Yang JL, et al. Gandoderma lucidum extract promotes immune responses in normal BALB/c mice In vivo. In Vivo. 2009 Sep-Oct;23(5):755-9.
7. Chen WY, Yang WB, Wong CH, et al. Effect of Reishi polysaccharides on human stem/progenitor cells. Bioorg Med Chem. 2010 Dec 15;18(24):8583-91.
8. Ji Z, Tang Q, Zhang J, et al. Immunomodulation of bone marrow macrophages by GLIS, a proteoglycan fraction from Lingzhi or Reishi medicinal mushroom Ganoderma lucidium (W.Curt.:Fr.) P. Karst. Int J Med Mushrooms. 2011;13(5):441-8.
9. Ruan W, Wei Y, Popovich DG. Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells. Phytother Res. 2015 Nov;29(11):1744-52.
10. Pan K, Jiang Q, Liu G, et al. Optimization extraction of Ganoderma lucidum polysaccharides and its immunity and antioxidant activities. Int J Biol Macromol. 2013 Apr;55:301-6.
11. Choi S, Nguyen VT, Tae N, et al. Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW264.7 cells. Toxicol Appl Pharmacol. 2014 Nov 1;280(3):434-42.
12. Chijioke O, Landtwing V, Munz C. NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection. Front Immunol. 2016;7:323.
13. Novakova L, Lehuen A, Novak J. Low numbers and altered phenotype of invariant natural killer T cells in recurrent varicella zoster virus infection. Cell Immunol. 2011;269(2):78-81.
14. Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol. 2013 Sep;132(3):515-25.
15. Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immunol. 2008 May;9(5):503-10.
16. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol. 2013;31:163-94.
17. Vidal SM, Khakoo SI, Biron CA. Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol. 2011 Dec;1(6):497-512.
18. Xu M, Muto T, Yabe T, et al. The relationship between the frequency of the common cold and the activities of natural killer cells. Environ Health Prev Med. 2000 Jan;4(4):212-6.
19. Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev. 2013 Sep;12(4):1069-78.
20. Ongradi J, Kovesdi V. Factors that may impact on immunosenescence: an appraisal. Immun Ageing. 2010 Jun 14;7:7.
21. Fuentes E, Fuentes M, Alarcon M, et al. Immune System Dysfunction in the Elderly. An Acad Bras Cienc. 2017 Jan-Mar;89(1):285-99.
22. Eo SK, Kim YS, Lee CK, et al. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol. 2000 Oct;72(3):475-81.
23. Avtonomova AV, Krasnopolskaya LM. Antiviral properties of basidiomycetes metabolites. Antibiot Khimioter. 2014;59(7-8):41-8.
24. Akihisa T, Nakamura Y, Tagata M, et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers. 2007 Feb;4(2):224-31.
25. Iwatsuki K, Akihisa T, Tokuda H, et al. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod. 2003 Dec;66(12):1582-5.
26. Li Y, Yang Y, Fang L, et al. Anti-hepatitis activities in the broth of Ganoderma lucidum supplemented with a Chinese herbal medicine. Am J Chin Med. 2006;34(2):341-9.
27. Li YQ, Wang SF. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett. 2006 Jun;28(11):837-41.
28. Liu J, Liang Q, Frost-Pineda K, et al. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1760-9.
29. Akbar R, Yam WK. Interaction of ganoderic acid on HIV related target: molecular docking studies. Bioinformation. 2011;7(8):413-7.
30. Wu Z, Zhang Y, Tan N, et al. ReishiMax extends the lifespan of mice: A preliminary report. The FASEB Journal. 2011 April 1, 2011;25(1 Supplement):601.2.
31. Novaro GM, Aronow HD, Mayer-Sabik E, et al. Plasma homocysteine and calcific aortic valve disease. Heart. 2004 Jul;90(7):802-3.
32. Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009 Apr;203(2):489-93.
33. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004 Nov;134(11):3100-5.
34. Fusaro M, Noale M, Viola V, et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res. 2012 Nov;27(11):2271-8.
35. Theuwissen E, Smit E, Vermeer C. The role of vitamin K in soft-tissue calcification. Adv Nutr. 2012 Mar 1;3(2):166-73.
36. Koos R, Mahnken AH, Muhlenbruch G, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol. 2005 Sep 15;96(6):747-9.
37. Schurgers LJ, Dissel PE, Spronk HM, et al. Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol. 2001;90 Suppl 3:57-63.
38. Shimizu T, Choudhry MA, Szalay L, et al. Salutary effects of androstenediol on cardiac function and splanchnic perfusion after trauma-hemorrhage. Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R386-90.
39. Lichte P, Pfeifer R, Werner BE, et al. Dehydroepiandrosterone modulates the inflammatory response in a bilateral femoral shaft fracture model. Eur J Med Res. 2014 May 19;19:27.
40. Haring R, Baumeister SE, Volzke H, et al. Prospective inverse associations of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress. J Androl. 2012 Sep-Oct;33(5):944-50.
41. Zhang K, Ma X, He W, et al. Extracts of Cistanche deserticola Can Antagonize Immunosenescence and Extend Life Span in Senescence-Accelerated Mouse Prone 8 (SAM-P8) Mice. Evid Based Complement Alternat Med. 2014;2014:601383.
42. Zhang YH, Wang LC, Tu PF, et al. Macrophage activation by low molecular weight saccharides from Cistanche deserticola. Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4207-10.
43. Zhang A, Yang X, Li Q, et al. Immunostimulatory activity of water-extractable polysaccharides from Cistanche deserticola as a plant adjuvant in vitro and in vivo. PLoS One. 2018;13(1):e0191356.
44. Yonei Y, Kitano T, Ogura M, et al. Effects of Health Food Containing Cistanche Deserticola Extract on QOL and Safety in Elderly: An Open Pilot Study of 12-week Oral Treatment. Anti-Aging Medicine. 2011;8(2):7-14.
45. Walston JD, Matteini AM, Nievergelt C, et al. Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults. Exp Gerontol. 2009 May;44(5):350-5.
46. Di Bona D, Vasto S, Capurso C, et al. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev. 2009 Jan;8(1):36-42.
47. Cohen HJ, Pieper CF, Harris T, et al. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997 Jul;52(4):M201-8.
48. Wassel CL, Laughlin GA, Barrett-Connor E. Abstract 1136: Association of C-reactive Protein (CRP) and Interleukin-6 (IL-6) With Longevity Into the 80s and 90s: The Rancho Bernardo Study. Circulation. 2009;120(suppl_18):S453-S.
49. Puzianowska-Kuznicka M, Owczarz M, Wieczorowska-Tobis K, et al. Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing. 2016;13:21.
50. Lee LK, Foo KY. Recent advances on the beneficial use and health implications of Pu-Erh tea. Food Research International. 2013 10//;53(2):619-28.
51. Zhang L, Shao WF, Yuan LF, et al. Decreasing pro-inflammatory cytokine and reversing the immunosenescence with extracts of Pu-erh tea in senescence accelerated mouse (SAM). Food Chem. 2012 Dec 15;135(4):2222-8.
52. Chu SL, Fu H, Yang JX, et al. A randomized double-blind placebo-controlled study of Pu’er tea extract on the regulation of metabolic syndrome. Chin J Integr Med. 2011 Jul;17(7):492-8.
53. Ugarte-Gil MF, Sanchez-Zuniga C, Gamboa-Cardenas RV, et al. Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population. Rheumatology (Oxford). 2015 Jul;54(7):1302-7.
54. Solana R, Tarazona R, Aiello AE, et al. CMV and Immunosenescence: from basics to clinics. Immun Ageing. 2012 Oct 31;9(1):23.
55. Pawelec G, McElhaney JE, Aiello AE, et al. The impact of CMV infection on survival in older humans. Curr Opin Immunol. 2012 Aug;24(4):507-11.
56. Wang GC, Kao WH, Murakami P, et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol. 2010 May 15;171(10):1144-52.
57. Schnabel RB, Yin X, Larson MG, et al. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1728-33.
58. Giovannini S, Onder G, Liperoti R, et al. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc. 2011 Sep;59(9):1679-85.
59. Hartford M, Wiklund O, Mattsson Hulten L, et al. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes. J Intern Med. 2007 Nov;262(5):526-36.
60. Hussein AA, Gottdiener JS, Bartz TM, et al. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study. Heart Rhythm. 2013 Oct;10(10):1425-32.
61. Mehrotra N, Freire AX, Bauer DC, et al. Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Ann Epidemiol. 2010 Mar;20(3):223-32.
62. Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009 Sep;6(9):e1000145.
63. Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum. 2009 Jul;60(7):2037-45.
64. Klein R, Myers CE, Cruickshanks KJ, et al. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2014 Apr 1;132(4):446-55.